Tapewire

Nasdaq · USD

TMCI

TREACE MEDICAL CONCEPTS, INC.

Export transactions ↓
Tapewire entity
5943
SEC CIK
0001630627
Parsed reports
290

Last 12 months

Inside the activity.

14 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202660
Jun 202650
Jul 202600
Aug 202630
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 12, 2024 Filed Sep 16, 2024 20:30 UTC
Scanlan Sean F.Chief Innovation Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 33,750 $0.00 Strike: $0.10 $0.00
Disclosure

SEC source: 0000950170-24-106856 · ownership.xml · derivative · entry 2

Scanlan Sean F. · CIK 0001856371 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 33,750 shares

Expires 2024-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vested in equal annual installments over 4 years, commencing on December 15, 2014 with the last installment vesting on December 15, 2018.

Read SEC document
September 12, 2024 Filed Sep 16, 2024 20:30 UTC
Scanlan Sean F.Chief Innovation Officer
Exercise / conversionCommon Stock 33,750 $0.10 $3,280.50
Disclosure

SEC source: 0000950170-24-106856 · ownership.xml · nonDerivative · entry 1

Scanlan Sean F. · CIK 0001856371 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,074

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 215,185 restricted stock units.

Read SEC document
August 15, 2024 Filed Aug 19, 2024 09:00 UTC PurchaseCommon Stock 84,000 $5.96 $501,034.80
Disclosure

SEC source: 0000950170-24-098286 · ownership.xml · nonDerivative · entry 1

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,223,441

F1 · price: The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $5.9100 to $6.0450 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

Read SEC document
August 14, 2024 Filed Aug 15, 2024 21:30 UTC
Treace John T.Director · Chief Executive Officer · 10% owner
PurchaseCommon Stock 85,000 $6.00 $510,314.50
Disclosure

SEC source: 0000950170-24-097694 · ownership.xml · nonDerivative · entry 1

Treace John T. · CIK 0001856380 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,473,095

F1 · price: The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $5.9500 to $6.0700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes 196,464 restricted stock units

Read SEC document
August 09, 2024 Filed Aug 10, 2024 01:30 UTC
Scanlan Sean F.Chief Innovation Officer
GrantCommon Stock 120,900 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-095009 · ownership.xml · nonDerivative · entry 1

Scanlan Sean F. · CIK 0001856371 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 216,324

F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in three equal annual installments on the first, second and third anniversaries of the grant date; subject to Reporting Person's providing continued service to Issuer through each vesting date.

F2 · balance_after: Includes 215,185 restricted stock units.

Read SEC document
August 09, 2024 Filed Aug 10, 2024 01:30 UTC
Hair MarkChief Financial Officer
GrantCommon Stock 207,260 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-095008 · ownership.xml · nonDerivative · entry 1

Hair Mark · CIK 0001725070 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 367,915

F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in three equal annual installments on the first, second and third anniversaries of the grant date; subject to Reporting Person's providing continued service to Issuer through each vesting date.

F2 · balance_after: Includes 349,767 restricted stock units.

Read SEC document
August 09, 2024 Filed Aug 10, 2024 01:30 UTC
Berutti AaronSVP, Sales
GrantCommon Stock 60,450 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-095010 · ownership.xml · nonDerivative · entry 1

Berutti Aaron · CIK 0001871334 · SVP, Sales

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,791

F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in three equal annual installments on the first, second and third anniversaries of the grant date; subject to Reporting Person's providing continued service to Issuer through each vesting date.

F2 · balance_after: Includes 161,711 restricted stock units

Read SEC document
August 09, 2024 Filed Aug 10, 2024 01:30 UTC
Elder Scot MichaelChief Legl & Comp Off, CorpSec
GrantCommon Stock 129,540 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-095007 · ownership.xml · nonDerivative · entry 1

Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 237,915

F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in three equal annual installments on the first, second and third anniversaries of the grant date; subject to Reporting Person's providing continued service to Issuer through each vesting date.

F2 · balance_after: Includes 233,637 restricted stock units.

Read SEC document
June 11, 2024 Filed Jun 11, 2024 21:30 UTC
Treace John T.Director · Chief Executive Officer · 10% owner
PurchaseCommon Stock 45,000 $5.88 $264,600.00
Disclosure

SEC source: 0000950170-24-072078 · ownership.xml · nonDerivative · entry 1

Treace John T. · CIK 0001856380 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,388,095

F1 · price: The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $5.6800 to $5.9100 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes 196,464 restricted stock units

Read SEC document
May 31, 2024 Filed Jun 3, 2024 16:30 UTC PurchaseCommon Stock 25,000 $6.05 $151,327.50
Disclosure

SEC source: 0000950170-24-068023 · ownership.xml · nonDerivative · entry 1

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,139,441

F1 · price: The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $5.9400 to $6.1800 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

Read SEC document
May 29, 2024 Filed May 30, 2024 17:04 UTC PurchaseCommon Stock 25,000 $5.20 $130,062.50
Disclosure

SEC source: 0000950170-24-066745 · ownership.xml · nonDerivative · entry 1

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,114,441

F1 · price: The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $5.1300 to $5.2900 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

Read SEC document
May 28, 2024 Filed May 29, 2024 16:33 UTC PurchaseCommon Stock 50,000 $5.07 $253,475.00
Disclosure

SEC source: 0000950170-24-065984 · ownership.xml · nonDerivative · entry 1

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,089,441

F1 · price: The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.9600 to $5.2000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

Read SEC document
May 24, 2024 Filed May 28, 2024 16:30 UTC PurchaseCommon Stock 18,000 $5.19 $93,501.00
Disclosure

SEC source: 0000950170-24-065263 · ownership.xml · nonDerivative · entry 1

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,072,944

F1 · price: The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $5.1200 to $5.2400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes 15,091 restricted stock units.

Read SEC document
May 22, 2024 Filed May 23, 2024 16:30 UTC PurchaseCommon Stock 12,100 $4.99 $60,424.98
Disclosure

SEC source: 0000950170-24-063988 · ownership.xml · nonDerivative · entry 1

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,054,944

F1 · price: The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.9600 to $5.0000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes 15,091 restricted stock units.

Read SEC document
May 21, 2024 Filed May 22, 2024 21:30 UTC
Hanna BetsyDirector
GrantStock Option (Right to Buy) · Derivative 33,260 $0.00 Strike: $4.97 $0.00
Disclosure

SEC source: 0000950170-24-063615 · ownership.xml · derivative · entry 2

Hanna Betsy · CIK 0001885957 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,260

Underlying: Common Stock · 33,260 shares

Expires 2034-05-21

F3 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 21, 2024, such that the stock option will be fully vested and exercisable on the earlier of (a) May 21, 2025, or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
May 21, 2024 Filed May 22, 2024 21:30 UTC
Hanna BetsyDirector
GrantCommon Stock 15,091 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-063615 · ownership.xml · nonDerivative · entry 1

Hanna Betsy · CIK 0001885957 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,326

F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 21, 2025 or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer.

F2 · balance_after: Includes 15,486 restricted stock units.

Read SEC document
May 21, 2024 Filed May 22, 2024 21:30 UTC GrantStock Option (Right to Buy) · Derivative 33,260 $0.00 Strike: $4.97 $0.00
Disclosure

SEC source: 0000950170-24-063613 · ownership.xml · derivative · entry 2

Berry Lance A · CIK 0001478716 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,260

Underlying: Common Stock · 33,260 shares

Expires 2034-05-21

F3 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 21, 2024, such that the stock option will be fully vested and exercisable on the earlier of (a) May 21, 2025, or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
May 21, 2024 Filed May 22, 2024 21:30 UTC GrantCommon Stock 15,091 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-063613 · ownership.xml · nonDerivative · entry 1

Berry Lance A · CIK 0001478716 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,676

F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 21, 2025 or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer.

F2 · balance_after: Includes 18,788 restricted stock units.

Read SEC document
May 21, 2024 Filed May 22, 2024 21:30 UTC GrantStock Option (Right to Buy) · Derivative 33,260 $0.00 Strike: $4.97 $0.00
Disclosure

SEC source: 0000950170-24-063617 · ownership.xml · derivative · entry 4

BAKEWELL JOHN K · CIK 0001183553 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,260

Underlying: Common Stock · 33,260 shares

Expires 2034-05-21

F3 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 21, 2024, such that the stock option will be fully vested and exercisable on the earlier of (a) May 21, 2025, or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
May 21, 2024 Filed May 22, 2024 21:30 UTC GrantCommon Stock 15,091 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-063617 · ownership.xml · nonDerivative · entry 1

BAKEWELL JOHN K · CIK 0001183553 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,139

F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 21, 2025 or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the issuer's Common Stock issuable upon settlement of the RSUs until the earlier of (a) a change in control, (b) the Reporting Person's separation of service to the Issuer, or (c) the fifth anniversary of the RSU's grant date.

F2 · balance_after: Includes 15,091 restricted stock units.

Read SEC document
May 21, 2024 Filed May 22, 2024 17:30 UTC GrantStock Option (Right to Buy) · Derivative 33,260 $0.00 Strike: $4.97 $0.00
Disclosure

SEC source: 0000950170-24-063614 · ownership.xml · derivative · entry 2

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,260

Underlying: Common Stock · 33,260 shares

Expires 2034-05-21

F3 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 21, 2024, such that the stock option will be fully vested and exercisable on the earlier of (a) May 21, 2025, or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
May 21, 2024 Filed May 22, 2024 17:30 UTC GrantCommon Stock 15,091 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-063614 · ownership.xml · nonDerivative · entry 1

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,042,844

F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 21, 2025 or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer.

F2 · balance_after: Includes 15,091 restricted stock units.

Read SEC document
May 21, 2024 Filed May 22, 2024 21:30 UTC GrantStock Option (Right to Buy) · Derivative 33,260 $0.00 Strike: $4.97 $0.00
Disclosure

SEC source: 0000950170-24-063611 · ownership.xml · derivative · entry 2

HAMILTON LAWRENCE W · CIK 0001326586 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,260

Underlying: Common Stock · 33,260 shares

Expires 2034-05-21

F3 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 21, 2024, such that the stock option will be fully vested and exercisable on the earlier of (a) May 21, 2025, or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
May 21, 2024 Filed May 22, 2024 21:30 UTC GrantCommon Stock 15,091 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-063611 · ownership.xml · nonDerivative · entry 1

HAMILTON LAWRENCE W · CIK 0001326586 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,139

F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 21, 2025 or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer.

F2 · balance_after: Includes 15,091 restricted stock units.

Read SEC document
May 21, 2024 Filed May 22, 2024 21:30 UTC GrantStock Option (Right to Buy) · Derivative 33,260 $0.00 Strike: $4.97 $0.00
Disclosure

SEC source: 0000950170-24-063616 · ownership.xml · derivative · entry 2

Kiernan Jane E · CIK 0001379171 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,260

Underlying: Common Stock · 33,260 shares

Expires 2034-05-21

F3 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 21, 2024, such that the stock option will be fully vested and exercisable on the earlier of (a) May 21, 2025, or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
May 21, 2024 Filed May 22, 2024 21:30 UTC GrantCommon Stock 15,091 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-063616 · ownership.xml · nonDerivative · entry 1

Kiernan Jane E · CIK 0001379171 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,032

F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 21, 2025 or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer.

F2 · balance_after: Includes 18,788 restricted stock units.

Read SEC document
May 21, 2024 Filed May 22, 2024 21:30 UTC
Jain DeeptiDirector
GrantStock Option (Right to Buy) · Derivative 33,260 $0.00 Strike: $4.97 $0.00
Disclosure

SEC source: 0000950170-24-063612 · ownership.xml · derivative · entry 2

Jain Deepti · CIK 0001840203 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,260

Underlying: Common Stock · 33,260 shares

Expires 2034-05-21

F3 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 21, 2024, such that the stock option will be fully vested and exercisable on the earlier of (a) May 21, 2025, or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
May 21, 2024 Filed May 22, 2024 21:30 UTC
Jain DeeptiDirector
GrantCommon Stock 15,091 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-063612 · ownership.xml · nonDerivative · entry 1

Jain Deepti · CIK 0001840203 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,326

F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 21, 2025 or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date.

F2 · balance_after: Includes 15,486 restricted stock units.

Read SEC document
May 17, 2024 Filed May 20, 2024 20:30 UTC
Treace John T.Director · Chief Executive Officer · 10% owner
PurchaseCommon Stock 100,000 $5.56 $556,170.00
Disclosure

SEC source: 0000950170-24-062435 · ownership.xml · nonDerivative · entry 1

Treace John T. · CIK 0001856380 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,343,095

F1 · price: The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $5.3943 to $5.7480 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes 196,464 restricted stock units

Read SEC document
May 14, 2024 Filed May 14, 2024 22:19 UTC
Treace John T.Director · Chief Executive Officer · 10% owner
PurchaseCommon Stock 150,000 $5.12 $767,805.00
Disclosure

SEC source: 0000950170-24-059854 · ownership.xml · nonDerivative · entry 1

Treace John T. · CIK 0001856380 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,243,095

F1 · price: The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.9800 to $5.3500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes 196,646 restricted stock units

Read SEC document
May 14, 2024 Filed May 14, 2024 22:20 UTC PurchaseCommon Stock 19,356 $5.17 $100,000.84
Disclosure

SEC source: 0000950170-24-059856 · ownership.xml · nonDerivative · entry 1

Kiernan Jane E · CIK 0001379171 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,941

F1 · price: The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $5.1490 to $5.1698 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes 5,585 restricted stock units

Read SEC document
May 13, 2024 Filed May 13, 2024 22:07 UTC
Treace John T.Director · Chief Executive Officer · 10% owner
PurchaseCommon Stock 150,000 $4.56 $683,490.00
Disclosure

SEC source: 0000950170-24-058878 · ownership.xml · nonDerivative · entry 2

Treace John T. · CIK 0001856380 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,093,095

F3 · price: The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3900 to $4.6400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes 196,646 restricted stock units

Read SEC document
May 13, 2024 Filed May 13, 2024 19:47 UTC PurchaseCommon Stock 145,000 $4.54 $657,981.00
Disclosure

SEC source: 0000950170-24-058986 · ownership.xml · nonDerivative · entry 2

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,039,441

F2 · price: The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3800 to $4.6400 0inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

Read SEC document
May 13, 2024 Filed May 13, 2024 19:48 UTC PurchaseCommon Stock 36,802 $4.38 $161,089.71
Disclosure

SEC source: 0000950170-24-058989 · ownership.xml · nonDerivative · entry 2

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,027,753

F3 · price: The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.320 to $4.5900 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes 2,753 restricted stock units

Read SEC document
May 10, 2024 Filed May 13, 2024 22:07 UTC
Treace John T.Director · Chief Executive Officer · 10% owner
PurchaseCommon Stock 150,000 $4.58 $686,880.00
Disclosure

SEC source: 0000950170-24-058878 · ownership.xml · nonDerivative · entry 1

Treace John T. · CIK 0001856380 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,943,095

F1 · price: The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.4700 to $4.7500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes 196,646 restricted stock units

Read SEC document
May 10, 2024 Filed May 13, 2024 23:30 UTC PurchaseCommon Stock 130,000 $4.57 $594,620.00
Disclosure

SEC source: 0000950170-24-058974 · ownership.xml · nonDerivative · entry 1

BAKEWELL JOHN K · CIK 0001183553 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,048

F1 · price: The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.425 to $4.6186, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes 2,753 restricted stock units.

Read SEC document
May 10, 2024 Filed May 13, 2024 19:47 UTC PurchaseCommon Stock 83,000 $4.53 $376,023.20
Disclosure

SEC source: 0000950170-24-058986 · ownership.xml · nonDerivative · entry 1

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 894,441

F1 · price: The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3300 to $4.7600 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

Read SEC document
May 10, 2024 Filed May 13, 2024 19:48 UTC PurchaseCommon Stock 83,198 $4.57 $379,848.79
Disclosure

SEC source: 0000950170-24-058989 · ownership.xml · nonDerivative · entry 1

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 990,951

F1 · price: The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.4000 to $4.6500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes 2,753 restricted stock units

Read SEC document
May 10, 2024 Filed May 13, 2024 23:49 UTC
Jain DeeptiDirector
PurchaseCommon Stock 25,000 $4.50 $112,567.50
Disclosure

SEC source: 0000950170-24-058990 · ownership.xml · nonDerivative · entry 1

Jain Deepti · CIK 0001840203 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,235

F1 · balance_after: Includes 3940 restricted stock units

Read SEC document
March 10, 2024 Filed Mar 13, 2024 01:30 UTC
Scanlan Sean F.Chief Innovation Officer
Tax withholdingCommon Stock 1,396 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-030429 · ownership.xml · nonDerivative · entry 2

Scanlan Sean F. · CIK 0001856371 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,424

F2 · balance_after: Includes 94,285 restricted stock units.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 01:55 UTC
Treace John T.Director · Chief Executive Officer · 10% owner
Tax withholdingCommon Stock 5,021 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-030472 · ownership.xml · nonDerivative · entry 2

Treace John T. · CIK 0001856380 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,793,095

F2 · balance_after: Includes 196,646 restricted stock units

Read SEC document
March 10, 2024 Filed Mar 13, 2024 01:55 UTC
Hair MarkChief Financial Officer
Tax withholdingCommon Stock 4,088 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-030474 · ownership.xml · nonDerivative · entry 2

Hair Mark · CIK 0001725070 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,655

F2 · balance_after: Includes 142,507 restricted stock units.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 01:55 UTC
Berutti AaronSVP, Sales
Tax withholdingCommon Stock 1,815 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-030473 · ownership.xml · nonDerivative · entry 2

Berutti Aaron · CIK 0001871334 · SVP, Sales

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,341

F2 · balance_after: Includes 101,261 restricted stock units

Read SEC document
March 10, 2024 Filed Mar 13, 2024 01:30 UTC
Elder Scot MichaelChief Legl & Comp Off, CorpSec
Tax withholdingCommon Stock 1,666 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-030426 · ownership.xml · nonDerivative · entry 2

Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,375

F2 · balance_after: Includes 104,097 restricted stock units.

Read SEC document
March 08, 2024 Filed Mar 13, 2024 01:30 UTC
Scanlan Sean F.Chief Innovation Officer
Tax withholdingCommon Stock 389 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-030429 · ownership.xml · nonDerivative · entry 1

Scanlan Sean F. · CIK 0001856371 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,820

F1 · balance_after: Includes 95,681 restricted stock units.

Read SEC document
March 08, 2024 Filed Mar 13, 2024 01:55 UTC
Treace John T.Director · Chief Executive Officer · 10% owner
Tax withholdingCommon Stock 2,064 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-030472 · ownership.xml · nonDerivative · entry 1

Treace John T. · CIK 0001856380 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,798,116

F1 · balance_after: Includes 201,667 restricted stock units

Read SEC document
March 08, 2024 Filed Mar 13, 2024 01:55 UTC
Hair MarkChief Financial Officer
Tax withholdingCommon Stock 1,067 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-030474 · ownership.xml · nonDerivative · entry 1

Hair Mark · CIK 0001725070 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,743

F1 · balance_after: Includes 146,595 restricted stock units.

Read SEC document
March 08, 2024 Filed Mar 13, 2024 01:55 UTC
Berutti AaronSVP, Sales
Tax withholdingCommon Stock 711 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-030473 · ownership.xml · nonDerivative · entry 1

Berutti Aaron · CIK 0001871334 · SVP, Sales

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,156

F1 · balance_after: Includes 103,076 restricted stock units

Read SEC document
March 08, 2024 Filed Mar 13, 2024 01:30 UTC
Elder Scot MichaelChief Legl & Comp Off, CorpSec
Tax withholdingCommon Stock 169 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-030426 · ownership.xml · nonDerivative · entry 1

Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,041

F1 · balance_after: Includes 105,763 restricted stock units.

Read SEC document
January 10, 2024 Filed Jan 13, 2024 02:00 UTC
Scanlan Sean F.Chief Innovation Officer
GrantStock Option (Right to Buy) · Derivative 73,200 $0.00 Strike: $13.46 $0.00
Disclosure

SEC source: 0001209191-24-001589 · doc4.xml · derivative · entry 2

Scanlan Sean F. · CIK 0001856371 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,200

Underlying: Stock Option (Right to Buy) · 73,200 shares

Expires 2034-01-10

F3 · derivative.exercise_date: The stock option vests in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and the last installment vesting on January 10, 2028, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.